Khaitan, CAM, HSF act on Fosun-owned Gland Pharma’s planned $780 mln IPO
BY Aparna Sai |
Khaitan & Co and Cyril Amarchand Mangaldas are advising Indian drugmaker Gland Pharma on its planned $780 million IPO, with Herbert Smith Freehills and S&R Associates acting for the bookrunners and lead managers.